Sanofi Partners with Chinese Industry Stakeholders to Co-create a New Out-of-Hospital Patient Care Ecosystem

Sanofi recently held the China Pharmaceutical Ecosystem Summit in Shanghai, bringing together business partners, DTP (Direct-to-Patient) pharmacy chain partners, and experts and scholars.In-depth discussions centered on core issues such as the construction of a patient service ecosystem and digital transformation, aiming to promote“Patient-Centered”ofOut-of-HospitalImplementation of the Professional Services Ecosystem。

Currently, the out-of-hospital pharmaceutical channels are undergoing a wave of transformation. Sanofi, as aInnovation-Driven, AI-Empoweredbiopharmaceutical companies will upgrade their service models, leveraging AI-driven data analytics to collaborate with partners in delivering precise and personalized pharmaceutical care to patients. The collaboration between the pharmaceutical industry and pharmacies will evolve from a traditional supply-demand relationship,To“Data-Driven, Business Empowerment, Service Co-Creation”transition toward deep ecological collaboration, jointly building a health management network that covers the entire patient lifecycle。

Sanofi Greater China President Shi Wang“China is Sanofi’s second-largest market globally and one of the most promising and innovative healthcare markets. Here, we not only introduce global innovations but also deeply engage in building the local innovation ecosystem—ranging from R&D collaborations to business model upgrades, and from patient services to supply chain synergy. We firmly believe that true innovation must be patient-centric. Therefore, we will continue to deepen our collaboration with industry partners to jointly create a more resilient and compassionate healthcare ecosystem in China.”

Xia Xiaoqin, Head of Sanofi China’s Retail BusinessAt the conference, a review of Sanofi’s DTP development journey was presented, stating: “The DTP model has currently entered Phase 3.0, characterized by model innovation. It has evolved from initially ensuring patient access, to establishing a patient-centric service model, and further to a personalized, precision-driven patient service model empowered by AI technology, which focuses on specific disease areas and integrates personalized service concepts. We look forward to collaborating with more like-minded pharmacy partners to co-build an ecosystem that delivers more precise, professional, and sustainable services to patients.”

Dr. Hu Qicong, Global Partner and Managing Director at Boston Consulting GroupShared insights on the development trends of the DTP channel in the pharmaceutical industry and explorations into patient service models. “Driven by multiple factors, including upgraded patient needs, the development of innovative drugs, and favorable policies, the overall scale of DTP pharmacies continues to grow. By building an integrated ‘pharmaceutical-medical-insurance-patient’ ecosystem and linking data with services, a full-cycle value loop can be achieved, enhancing patient accessibility, improving treatment adherence, and optimizing healthcare payment.”

At the conference, Sanofi joined hands with its partners to jointly launch“"Feiyue's New Journey"”Patient Services Ecosystem Co-Creation ProjectIn the future, in-depth cooperation will center on “patient services, ecosystem co-creation, and digital-intelligence drive,” propelling the development of the DTP (Direct-to-Patient) pharmacy ecosystem into a new phase. With continued exploration and implementation of innovative models, out-of-hospital pharmacies are poised to play a more active role in connecting hospitals, pharmaceutical companies, and patients, thereby delivering greater value in areas such as tiered diagnosis and treatment, chronic disease management, and rare disease coverage. This summit has established an important platform for exchange. Looking ahead, Sanofi will continue to collaborate with industry partners to jointly explore the boundless possibilities of the DTP pharmacy ecosystem and make sustained contributions toward achieving the “Healthy China 2030” initiative.